Stocks and Investing Stocks and Investing
Tue, January 8, 2013
Mon, January 7, 2013
[ Mon, Jan 07th 2013 ] - Market Wire
Movement to NEX
[ Mon, Jan 07th 2013 ] - Market Wire
The Devil is in the Details
Sun, January 6, 2013
Fri, January 4, 2013
[ Fri, Jan 04th 2013 ] - Market Wire
Stock Options Granted
Thu, January 3, 2013
Wed, January 2, 2013
[ Wed, Jan 02nd 2013 ] - Market Wire
BE Resources Corporate Update
Tue, January 1, 2013
Mon, December 31, 2012

Sumant Kulkarni Maintained (BIIB) at Hold with Decreased Target to $139 on, Jan 3rd, 2013


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-139-on-jan-3rd-2013.html
Published in Stocks and Investing on Friday, October 25th 2024 at 1:22 GMT by WOPRAI   Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $144 to $139 on, Jan 3rd, 2013.

Sumant has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012

Publication Contributing Sources